IONM During Radical Prostatectomy

Launched by THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE · Apr 22, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how to improve a common surgery for prostate cancer called radical prostatectomy. One of the main goals is to help prevent complications that can happen after the surgery, like urinary incontinence (trouble controlling urine) and erectile dysfunction (difficulty getting or maintaining an erection). The researchers want to use a special method during the surgery to monitor and protect the nerves that control these functions, which could lead to better outcomes for patients.

To participate in this study, men aged 65 to 74 who are being treated for prostate cancer at the hospital can join if they fully understand the study and are willing to share their medical history. However, those who do not actually have prostate cancer, have certain medical devices like pacemakers, or have serious neurological or mental health issues may not be eligible. Participants can expect to have their nerves closely monitored during the surgery, which is hoped to reduce the risk of complications afterward. It's important for prospective participants to know that this trial is not yet recruiting, but it aims to help many men who face challenges after prostate cancer surgery.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • - 1: Prostate cancer patients undergoing surgical treatment in our Hospital 2: Understand the content of this study, actively provide complete and true medical history and examination data, and be willing to cooperate with postoperative interviewers.
• • 3: Voluntarily participate in the study and sign the treatment document within the ethical framework.
• Exclusion Criteria:
• • 1: Histopathology showed that the patient did not have prostate cancer 2: Use a cardiac pacemaker or other electromechanical prosthesis device 3: Suffering from a serious neurological disease, mental illness or other illness that may be life-threatening within two years